News

Filter

Current filters:

Aastrom Biosciences

Aastrom Biosciences to re-focus on DCM program, and cut workforce

28-03-2013

US cardiovascular drug developer Aastrom Biosciences (NasdaqCM: ASTM) has announced a strategic change…

Aastrom BiosciencesBiotechnologyCardio-vascularixmyelocel-TManagementResearch

Back to top